Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
TELA Bio is a life science company that specializes in soft tissue reconstruction.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Congruence Therapeutics operates as a biotechnology company.
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Leal Therapeutics develops novel therapeutics for patients.
ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.
Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Forte Biosciences is a biotechnology company that focuses on dermatology.
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Medical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Mineralys Therapeutics received $287.5M in a Post Ipo Equity round. OrbiMed's total known invested capital is $23.6B.
OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include BlossomHill Therapeutics, Proviva Therapeutics, Invivyd, Verastem Oncology, TandemAI. These companies were founded in 2020 or later.